Erratum: Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery (Journal of Neuro-Oncology DOI: 10.1007/s11060-010-0235-4);Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery

Journal of Neuro-Oncology

Volumn 101, Issue 1, 2011, Pages 101-106

  Zachenhofer, Iris ^a   Donat, Markus ^a   Oberndorfer, Stefan ^b   Roessler, Karl ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Chemotherapy; Epilepsy; Levetiracetam; Perioperative anticonvulsants; Supratentorial brain tumors

Indexed keywords

CYTOCHROME P450; ETIRACETAM;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BRAIN METASTASIS; BRAIN SURGERY; BRAIN TUMOR; CANCER SURGERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME INDUCTION; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PSYCHOSIS; RADIATION NECROSIS; SEIZURE; SEIZURE THRESHOLD; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; TREATMENT DURATION; TUMOR LOCALIZATION;

EID: 78651333158     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0298-2     Document Type: Erratum

References (48)

1. B Abou-Khalil L Schaich 2005 Long-term efficacy of levetiracetam for partial seizures Seizure 14 577 585 10.1016/j.seizure.2005.09.003 16280250
2. RD Barr SA Copeland ML Stockwell N Morris JC Kelton 1982 Valproic acid and immune thrombocytopenia Arch Dis Child 57 681 684 1:STN:280: DyaL3s%2FitFelsg%3D%3D 10.1136/adc.57.9.681 6812506
3. J Bauer E Ben-Menachem G Krämer W Fryze S Da Silva DG Kasteleijn-Nolst Trenité 2006 Levetiracetam: a long-term follow-up study of efficacy and safety Acta Neurol Scand 114 169 176 1:CAS:528: DC%2BD28XhtVGitLvM 10.1111/j.1600-0404.2006.00657.x 16911344
4. LF Beenen J Lindeboom DG Kasteleijn-Nolst Trenité JJ Heimans FJ Snoek DJ Touw HJ Adèr HA van Alphen 1999 Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects J Neurol Neurosurg Psychiatry 67 474 480 1:STN:280:DyaK1MvhslOnug%3D%3D 10.1136/jnnp.67.4.474 10486394
5. E Ben-Menachem E Gilland 2003 Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy Seizure 12 131 135 10.1016/S1059-1311(02)00251-0 12651076
6. GD Cascino 1990 Epilepsy and brain tumors: implications for treatment Epilepsia 31 suppl 3 S37 S44 10.1111/j.1528-1157.1990.tb05858.x 2121472
7. JB Chalk K Ridgeway T Brophy JD Yelland MJ Eadie 1984 Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients J Neurol Neurosurg Psychiatry 47 1087 1090 1:STN:280:DyaL2M%2FlslSjug%3D%3D 10.1136/jnnp.47.10.1087 6502166
8. A De Santis R Villani M Sinisi N Stocchetti E Perucca 2002 Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study Epilepsia 43 175 182 10.1046/j.1528-1157. 2002.24801.x 11903465
9. G Flesch 2004 Overview of the clinical pharmacokinetics of oxcarbazepine Clin Drug Investig 24 185 203 1:CAS:528:DC%2BD2cXjslGqt7k%3D 10.2165/00044011-200424040-00001 17516704
10. NB Fountain 2009 Should levetiracetam replace phenytoin for seizure prophylaxis after neurosurgery? Epilepsy Curr 9 71 72 10.1111/j.1535-7511.2009. 01297.x 19471614
11. ML Friis O Kristensen J Boas M Dalby SH Deth L Gram M Mikkelsen B Pedersen A Sabers J Worm-Petersen, et al. 1993 Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment Acta Neurol Scand 87 224 227 1:STN:280:DyaK3s3jsFGguw%3D%3D 10.1111/j.1600-0404.1993.tb04106.x 8475694
12. MJ Glantz BF Cole PA Forsyth LD Recht PY Wen MC Chamberlain SA Grossman JG Cairncross 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 54 1886 1893 1:STN:280: DC%2BD3c3osVWhsA%3D%3D 10822423
13. SA Grossman VR Sheidler MR Gilbert 1989 Decreased phenytoin levels in patients receiving chemotherapy Am J Med 87 505 510 1:STN:280: DyaK3c%2FltlKhug%3D%3D 10.1016/S0002-9343(89)80605-9 2683764
14. J Hildebrand C Lecaille J Perennes JY Delattre 2005 Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology 65 212 215 10.1212/01.wnl.0000168903.09277.8f 16043788
15. KD Holland 2001 Efficacy, pharmacology, and adverse effects of antiepileptic drugs Neurol Clin 19 313 345 1:STN:280:DC%2BD3M3mvVSltg%3D%3D 10.1016/S0733-8619(05)70021-9 11358747
16. B Kis Z Szupera Z Mezei A Gecse G Telegdy L Vécsei 1999 Valproate treatment and platelet function: the role of arachidonate metabolites Epilepsia 40 307 310 1:CAS:528:DyaK1MXmt1WlsLc%3D 10.1111/j.1528-1157.1999.tb00709.x 10080510
17. JM Kuijlen OP Teernstra AG Kessels MJ Herpers EA Beuls 1996 Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis Seizure 5 291 298 1:STN:280:DyaK2s7gvFOgtw%3D%3D 10.1016/S1059-1311(96)80023-9 8952015
18. LA Lawson RA Blouin RB Smith RP Rapp AB Young 1981 Phenytoin- dexamethasone interaction: a previously unreported observation Surg Neurol 16 23 24 1:STN:280:DyaL38%2Fhslyhtg%3D%3D 10.1016/S0090-3019(81)80054-7 7280966
19. ST Lee TN Lui CN Chang WC Cheng DJ Wang RF Heimburger CG Lin 1989 Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures Surg Neurol 31 361 364 1:STN:280:DyaL1M3it1Ogsg%3D%3D 10.1016/0090-3019(89)90067-0 2711309
20. C Liddle BJ Goodwin J George M Tappner GC Farrell 1998 Separate and interactive regulation of cytochrome P 450 3A4 by trijodothyronine, dexamethasone, and growth hormone in cultured hepatocytes J Clin Endocrinol Metab 83 2411 2416 1:CAS:528:DyaK1cXksVSisr8%3D 10.1210/jc.83.7.2411 9661620
21. DA Lim P Tarapore E Chang M Burt L Chakalian N Barbaro S Chang KR Lamborn MW McDermott 2009 Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study J Neurooncol 93 349 354 1:CAS:528:DC%2BD1MXmsVClsb4%3D 10.1007/s11060-008-9781-4 19169651
22. P Lloyd G Flesch W Dieterle 1994 Clinical pharmacology and pharmacokinetics of oxcarbazepine Epilepsia 35 suppl 3 S10 S13 10.1111/j.1528-1157.1994.tb05938.x 8156973
23. S Lwu MG Hamilton PA Forsyth JG Cairncross IF Parney 2010 Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience J Neurooncol 96 403 408 10.1007/s11060-009-9977-2 19669097
24. M Maschio F Albani A Baruzzi A Zarabla L Dinapoli A Pace A Pompili CM Carapella E Occhipinti B Jandolo 2006 Levetiracetam therapy in patients with brain tumour and epilepsy J Neurooncol 78 99 102 10.1007/s11060-005-9070-4
25. M Maschio L Dinapoli S Gomellini V Ferraresi F Sperati A Vidiri P Muti B Jandolo 2009 Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy J Neurooncol 98 1 109 116 10.1007/s11060-009-0069-0 19937087
26. TA Milligan S Hurwitz EB Bromfield 2008 Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery Neurology 71 665 669 1:CAS:528:DC%2BD1cXpvFygtbw%3D 10.1212/01.wnl.0000324624.52935.46 18725591
27. S Mintzer RT Mattson 2009 Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia 50 suppl 8 S42 S50 10.1111/j.1528-1167. 2009.02235.x
28. W Nasreddine A Beydoun 2008 Valproate-induced thrombocytopenia: a prospective monotherapy study Epilepsia 49 438 445 1:CAS:528: DC%2BD1cXktVOjsLg%3D 10.1111/j.1528-1167.2007.01429.x 18031547
29. JB North RK Penhall A Hanieh DB Frewin WB Taylor 1983 Phenytoin and postoperative epilepsy. A double-blind study J Neurosurg 58 672 677 1:STN:280:DyaL3s7mtleksg%3D%3D 10.3171/jns.1983.58.5.0672 6339686
30. S Oberndorfer M Piribauer C Marosi H Lahrmann P Hitzenberger W Grisold 2005 P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy J Neurooncol 72 255 260 1:CAS:528:DC%2BD28Xltg%3D%3D 10.1007/s11060-004-2338-2 15937649
31. PN Patsalos 2003 The pharmacokinetic characteristics of levetiracetam Methods Find Exp Clin Pharmacol 25 123 129 1:CAS:528:DC%2BD3sXjtlKhsbw%3D 10.1358/mf.2003.25.2.723686 12731458
32. PN Patsalos 2004 Clinical pharmacokinetics of levetiracetam Clin Pharmacokinet 43 704 724 10.2165/00003088-200443110-00002
33. E Perucca 1990 The clinical pharmacokinetics of the new antiepileptic drugs Epilepsia 40 suppl 9 S7 S13
34. S Pursche E Schleyer M von Bonin G Ehninger SM Said R Prondzinsky T Illmer Y Wang C Hosius Z Nikolova M Bornhäuser G Dresemann 2008 Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients Curr Clin Pharmacol 3 198 203 1:CAS:528: DC%2BD1MXitF2hsbc%3D 10.2174/157488408785747656 18781906
35. WE Rosenfeld S Benbadis P Edrich CA Tassinari E Hirsch 2009 Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies Epilepsy Res 85 72 80 1:CAS:528:DC%2BD1MXnt1eqs7o%3D 10.1016/j.eplepsyres.2009.02.016 19327967
36. SC Schachter 1999 Oxcarbazepine: current status and clinical applications Expert Opin Investig Drugs 8 1103 1112 1:CAS:528:DyaK1MXktlOltro%3D 10.1517/13543784.8.7.1103 15992110
37. R Stupp ME Hegi WP Mason MJ van den Bent MJ Taphoorn RC Janzer SK Ludwin A Allgeier B Fisher K Belanger P Hau AA Brandes J Gijtenbeek C Marosi CJ Vecht K Mokhtari P Wesseling S Villa E Eisenhauer T Gorlia M Weller D Lacombe JG Cairncross RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group 2009 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459 466 1:CAS:528:DC%2BD1MXlsVKhs74%3D 10.1016/S1470-2045(09)70025-7 19269895
38. Z Szupera Z Mezei B Kis A Gecse L Vécsei G Telegdy 2000 The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets Eur J Pharmacol 387 205 210 1:CAS:528: DC%2BD3cXmtVygtA%3D%3D 10.1016/S0014-2999(99)00764-5 10650161
39. NR Temkin 2002 Prophylactic anticonvulsants after neurosurgery Epilepsy Curr 2 105 107 10.1046/j.1535-7597.2002.00038.x 15309132
40. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421 430 10.1016/S1474-4422(07)70103-5 17434097
41. MS van Breemen RM Rijsman MJ Taphoorn R Walchenbach H Zwinkels CJ Vecht 2009 Efficacy of anti-epileptic drugs in patients with gliomas and seizures J Neurol 256 1519 1526 10.1007/s00415-009-5156-9 19434440
42. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 1:CAS:528:DC%2BD3sXms1yhsLk%3D 10.1016/S1474-4422(03)00435-6 12849118
43. JG Villemure N de Tribolet 1996 Epilepsy in patients with central nervous system tumors Curr Opin Neurol 9 424 428 1:STN:280:DyaK2s7lvFyrsQ%3D%3D 10.1097/00019052-199612000-00005 9007399
44. K Villikka KT Kivistö H Mäenpää H Joensuu PJ Neuvonen 1999 Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors Clin Pharmacol Ther 66 589 593 1:CAS:528:DC%2BD3cXlsVanuw%3D%3D 10613614
45. Wagner GL, Wilms EB, Vecht ChJ (2002) Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties. Ned Tijdschr Geneeskd. 146:1218-1221 (Review: Dutch)
46. GL Wagner EB Wilms CA Van Donselaar ChJ Vecht 2003 Levetiracetam: preliminary experience in patients with primary brain tumours Seizure 12 585 586 1:STN:280:DC%2BD3srltFynsA%3D%3D 10.1016/S1059-1311(03)00096-7 14630498
47. PY Wen PW Marks 2002 Medical management of patients with brain tumors Curr Opin Oncol 14 299 307 10.1097/00001622-200205000-00008 11981275
48. KY Yap WK Chui A Chan 2008 Drug interactions between chemotherapeutic regimens and antiepileptics Clin Ther 30 1385 1407 1:CAS:528:DC%2BD1cXhtF2rtLfI 10.1016/j.clinthera.2008.08.011 18803983